Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Iowa by County

Non-Hodgkin Lymphoma (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Iowa3


US (SEER+NPCR)1


Jones County7


Dubuque County7


Webster County7


Clinton County7


Dallas County7


Benton County7


Scott County7


Mahaska County7


Boone County7


Plymouth County7


Buchanan County7


Des Moines County7


Woodbury County7


Polk County7


Jefferson County7


Jasper County7


Lee County7


Pottawattamie County7


Page County7


Floyd County7


Story County7


Johnson County7


Sioux County7


Bremer County7


Fayette County7


Wapello County7


Warren County7


Marshall County7


Dickinson County7


Black Hawk County7


Linn County7


Butler County7


Kossuth County7


Cedar County7


Harrison County7


Henry County7


Cerro Gordo County7


Madison County7


Delaware County7


Clayton County7


Marion County7


Tama County7


Wright County7


Clay County7


Muscatine County7


Cass County7


Carroll County7


Washington County7


Franklin County7


Hardin County7


O'Brien County7


Mitchell County7


Adair County7 Adams County7 Allamakee County7 Appanoose County7 Audubon County7 Buena Vista County7 Calhoun County7 Cherokee County7 Chickasaw County7 Clarke County7 Crawford County7 Davis County7 Decatur County7 Emmet County7 Fremont County7 Greene County7 Grundy County7 Guthrie County7 Hamilton County7 Hancock County7 Howard County7 Humboldt County7 Ida County7 Iowa County7 Jackson County7 Keokuk County7 Louisa County7 Lucas County7 Lyon County7 Mills County7 Monona County7 Monroe County7 Montgomery County7 Osceola County7 Palo Alto County7 Pocahontas County7 Poweshiek County7 Ringgold County7 Sac County7 Shelby County7 Taylor County7 Union County7 Van Buren County7 Wayne County7 Winnebago County7 Winneshiek County7 Worth County7

Notes:
Created by statecancerprofiles.cancer.gov on 07/13/2024 12:12 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
3 Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
7 Source: SEER November 2022 submission.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.